ANIX vs CUBE · rev $210.0K vs P/E 25, rev $1.07B
Anixa Biosciences Inc (ANIX) versus CubeSmart (CUBE) — a side-by-side from cached financials, not a winner call.
Anixa Biosciences Inc (ANIX) is a biotechnology company listed on US.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Latest reported ANIX revenue for 2024-10-31 was $210.0K. Net income was -$12.7M. Revenue was up 0.0% from 2023-10-31 to 2024-10-31. ANIX currently screens at market cap $101.1M.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
ANIX currently screens at market cap $101.1M. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Not investment advice. Open the ANIX and CUBE stock pages for the full models.
Not investment advice.